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Background:  Although it has been known that myofibroblast (MFB) has conduction property and automaticity, MFB has never be found in human 
atrial tissue. Therefore, we hypothesized that MFBs exist in human atrial tissue with long-standing valvular atrial fibrillation (AF) and are related with 
structural remodeling of left atrium (LA).
Methods:  We analyzed immunohistochemical staining with human atrial appendage tissues in 17 patients with valvular AF (Male 41.2 %, 
60.8±10.1 years old) and 15 patients with SR (Male 60.0 %, 46.5±14.7 years old) who underwent cardiac valve surgery. MFB was defined by 
_-Smooth muscle actin (_-SMA) + cells with disorganized Cx43+ gap junctions in Sirus red + fibrotic area. We quantified MFB depending on the 
existence of AF and LA size, and co-localization pattern.
Results:  1. MFBs existed in 7/17 (41.2%) patients with AF (0.059±0.179% area) and 2/15 (13.3%) patients in SR group (0.006±0.017% area, 
p=0.1175), predominantly in endocardial smooth muscle layer. In patients whose LA size ≤ 60 mm, % are of MFBs was higher in patients with AF 
compared with those SR (0.024±0.037% area vs. 0.003±0.011% area, p=0.0261). 2. The patients who showed MFBs in atrial tissues had greater 
amount of fibrosis (23.9±11.6% vs. 16.6±9.3%, p=0.0304) and greater LA size (64.2±14.0 mm vs. 53.9±12.8 mm, p=0.0238). 3. MFBs were co-
localized with PAS+ glycogen storage cells (95.5%) and CD117/c-kit+ cardiac stem cells (100%).
Conclusions:  MFB does exist in human atrial appendage tissues of valvular heart disease, and is related with LA size, existence of AF, and cardiac 
stem cells.
